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Background: Modified ultrafiltration has been touted as superior to conventional
ultrafiltration for attenuating the consequences of hemodilution after cardiac
surgery with cardiopulmonary bypass in children. We conducted a prospective ran-
domized study to test the hypothesis that modified and conventional ultrafiltration
have similar clinical effects when a standardized volume of fluid is removed.
Methods: From October 1998 to September 1999, 110 children weighing 15 kg or less
(median weight 6.1 kg, median age 6.3 months) undergoing surgery with cardiopul-
monary bypass for functionally biventricular congenital heart disease were randomized
to conventional (n = 67) or arteriovenous modified ultrafiltration (n = 43) for hemo-
concentration. The volume of fluid removed with both methods was standardized as a
percentage of effective fluid balance (the sum of prime volume and volume added dur-
ing cardiopulmonary bypass minus urine output): in patients weighing less than 10 kg,
50% of effective fluid balance was removed, whereas 60% was removed in patients
weighing 10 to 15 kg. Hematocrit, hemodynamics, ventricular function, transfusion of
blood products, and postoperative resource use were compared between groups.
Results: There were no significant differences between groups in age, weight, or
duration of cardiopulmonary bypass. The total volume of fluid added in the prime
and during bypass was greater in patients undergoing conventional ultrafiltration
than in those receiving modified ultrafiltration (205 ± 123 vs 162 ± 74 mL/kg; P =
.05), although the difference was due primarily to a greater indexed priming volume
in patients having conventional ultrafiltration. There was no difference in the per-
centage of effective fluid balance that was removed in the 2 groups. Accordingly,
the volume of ultrafiltrate was greater in patients receiving conventional than mod-
ified ultrafiltration (95 ± 63 vs 68 ± 28 mL/kg; P = .01). Preoperative and postop-
erative hematocrit levels were 35.6% ± 6.6% and 36.3% ± 5.6% in patients having
conventional ultrafiltration and 34.4% ± 6.7% and 38.7% ± 7.5% in those having
modified ultrafiltration. By repeated-measures analysis of variance, patients receiv-
ing modified and conventional ultrafiltration did not differ with respect to hemat-
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Ultrafiltration has become an importantstrategy for mitigating the adverse effectsof hemodilution that occur in childrenundergoing cardiac surgery with the useof cardiopulmonary bypass (CPB). Inpediatric cardiac surgical practice, there
are 2 basic approaches to ultrafiltration in wide use.1
Conventional ultrafiltration (CUF) involves ultrafiltration
during the rewarming phase of CPB. Because the patient
remains on CPB, the volume of fluid removed with CUF
may be limited by circuit volume, insofar as sufficient vol-
ume in the venous reservoir is necessary to ensure adequate
arterial inflow. In contrast, modified ultrafiltration (MUF) is
performed after discontinuation of CPB and is independent
of circuit volume. Because of this technical difference, more
fluid can often be removed with MUF than with CUF,
assuming that no or minimal additional volume is added to
the circuit during CUF. This difference may translate into
greater efficacy in attenuating the deleterious effects of
hemodilution. Although a number of studies have investi-
gated the potential advantages of MUF,2-11 the issue of
whether MUF has any intrinsic benefit over CUF aside from
the potentially greater volume of fluid removed has not been
investigated. To test the hypothesis that there is no benefit,
we conducted a prospective randomized study comparing
the effects of MUF and CUF in infants and young children
when a standardized volume of fluid is removed during the
ultrafiltration process. The results of this investigation are
described in the present report.
Patients and Methods
Patients
Between October 1998 and September 1999, 110 patients weigh-
ing 15 kg or less undergoing surgery for biventricular congenital
heart disease with the use of CPB were enrolled prospectively. The
study was conducted at 3 hospitals staffed by surgeons from our
group: University of California at San Francisco Medical Center,
Valley Children’s Hospital in Fresno, and Children’s Hospital of
Oakland, with the same methods of CPB and ultrafiltration used at
all 3 centers. Exclusion criteria included preoperative mechanical
ventilatory support and ongoing corticosteroid therapy for any rea-
son. Patients were randomized to surgery with CUF (n = 67) or
MUF (n = 43), with separate randomization at each site. A wide
range of functionally biventricular heart defects was represented,
with the majority of patients in both groups having atrial septal
defect, ventricular septal defect, tetralogy of Fallot, or transposi-
tion of the great arteries.
Cardiopulmonary Bypass
Our standard pediatric perfusion protocol was used in all patients,
with aortic and bicaval cannulation and flow rates of 125 to 200
mL · kg–1 · min–1, depending on weight, to maintain mixed venous
oxygen saturations of 60% to 70%. Blood prime was used, with
priming volume determined by the sizes of arterial and venous tub-
ing. Cold sanguineous crystalloid cardioplegic solution was used
during aortic crossclamping. Circulatory arrest was not used.
Ultrafiltration
The volume of fluid removed with both CUF and MUF was stan-
dardized according to a set percentage of effective fluid balance.
Effective fluid balance was defined as the sum of the priming vol-
ume and volume added during CPB (cardioplegic solution includ-
ed), less urine output. In patients less than 10 kg, the target ultra-
filtrate volume was 50% of the effective fluid balance, and in
patients weighing between 10 and 15 kg, it was 60% of the effec-
tive fluid balance. With both MUF and CUF, a Hemocor HPH 400
Minntech hemofilter (Minntech Corporation, Minneapolis, Minn)
was primed with Normosol R solution, pH 7.4. 
During CUF, ultrafiltration was conducted during the rewarm-
ing phase of CPB. The hemofilter was connected by 1⁄4-inch tubing
to the venous reservoir, proximal to a roller pump head, which
pulled blood from the venous reservoir through the hemofilter at a
rate of 15 to 30 mL · kg–1 · min–1, returning the concentrated blood
to the cardiotomy reservoir. The suction port to the hemoconcen-
trator was clamped until the target flow rate was reached; then suc-
tion was applied to the filtration port and regulated to a pressure up
to –180 mm Hg.
In the MUF group, arteriovenous MUF was performed after dis-
continuation of CPB until the goal volume of ultrafiltrate effluent
was reached. Via a 1⁄4-inch recirculation line distal to the arterial fil-
ter, blood was pulled through a separate roller pump head, allowing
for simultaneous ultrafiltration of the patient’s blood and residual
pump volume. Blood was pumped through the hemofilter and heat
exchanger, with air trapping capacity to maintain a temperature of
ocrit value (P = .87), mean arterial pressure (P = .85), heart rate (P = .43), or left
ventricular shortening fraction (P = .21) from baseline to the postbypass measure-
ments. There were no differences between groups in duration of mechanical venti-
lation, stay in the intensive care unit, or hospitalization.
Conclusions: When a standardized volume of fluid is removed, hematocrit, hemo-
dynamics, ventricular function, requirement for blood products, and postoperative
resource use do not differ between pediatric patients receiving conventional and
modified ultrafiltration for hemoconcentration after cardiac surgery. 
222 The Journal of Thoracic and Cardiovascular Surgery • August 2001
ED
ITO
RIA
L
CH
D
CH
D
A
CD
ET
CSP
TX
Surgery for Congenital Heart Disease Thompson et al
37°C. The flow rate through the hemofilter and filtration suction
pressure were the same as with CUF. The concentrated blood was
returned to the right atrium through a single angled-tip venous can-
nula. Patients in the MUF group did not receive CUF.
Data Analysis
Perioperative data were collected prospectively and are expressed as
median and range or mean ± standard deviation unless otherwise
specified. Odds ratios (OR) are presented with 95% confidence inter-
vals (95% CI). Comparison between patients who received MUF and
those who received CUF was conducted with respect to preoperative,
intraoperative, and postoperative variables including age, weight,
height, duration of CPB and aortic crossclamping, heart rate, blood
pressure, left ventricular shortening fraction, receipt of blood prod-
ucts (red blood cells, platelets, and plasma), chest tube drainage,
duration of mechanical ventilatory support, duration of stay in the
intensive care unit, and duration of hospitalization. For continuous
variables comparing serial values after baseline measurements before
CPB, repeated-measures analysis of variance (ANOVA) was used.
For comparison between CUF and MUF groups of dichotomous and
continuous variables not measured serially, χ2 analysis and indepen-
dent samples t test were used, respectively. The software package
SPSS for Windows version 7.0 (SPSS Inc, Chicago, Ill) was used for
statistical analysis. 
Results
Patients
Patients ranged in age from 1 day to 5 years (median 6.3
months), in weight from 2.4 to 15 kg (median 6.1 kg), and
in height from 23 to 100 cm (median 66 cm). There was no
significant difference in any of these variables between
patients in the CUF and MUF groups, although patients
undergoing MUF weighed more to a degree that approached
significance (Table 1).
CPB and Ultrafiltration
There was no difference in duration of CPB (119 ± 54 vs
118 ± 46 minutes; P = .88) or aortic crossclamping (53 ± 34
vs 51 ± 34 minutes; P = .72) between patients undergoing
CUF and MUF.
The total indexed volume of fluid received in the pump
prime and during CPB was significantly greater in patients
undergoing CUF than those receiving MUF (Table 2). This
difference was primarily due to a significantly larger relative
prime volume in patients undergoing CUF. Although the
indexed volume of fluid received during CPB was also larg-
er in patients receiving CUF, this difference was not statisti-
cally significant (Table 2). Urine output during CPB did not
differ between groups. The effective fluid balance, defined
as total fluid received in the prime and during CPB minus
urine output, was greater in patients undergoing CUF to a
degree that approach statistical significance (Table 2). In
both groups, an average of approximately 50% of effective
fluid balance was removed in the ultrafiltration effluent. The
proportion of patients in whom 90% or more of the target
ultrafiltration volume was removed (ie, ≥45% in patients
<10 kg, ≥54% in patients between 10 and 15 kg) was
approximately 80%, with no difference between CUF and
MUF groups (Table 2).
Hemodynamics and Ventricular Function
There were no differences in heart rate between patients in
the CUF and MUF groups at baseline, 10 minutes after
completion of extracorporeal circulation (ie, CPB or ultra-
filtration), or 1 hour after extracorporeal circulation.
Likewise, the trend in heart rate across these time points did
not differ between groups by repeated-measures ANOVA (P
= .43, Figure 1, A). Mean arterial blood pressure was lower
at baseline and 10 minutes after CPB in the CUF group but
did not differ significantly 1 hour after CPB or across time
by repeated-measures ANOVA (P = .85, Figure 1, B). Left
ventricular shortening fraction did not differ between CUF
and MUF patients at baseline, immediately after extracor-
poreal circulation, or 10 minutes after extracorporeal circu-
lation, nor was there a difference in the trend over time by
repeated-measured ANOVA (P = .21, Figure 1, C).
Blood Requirement and Postoperative Resource Use
No difference in baseline hematocrit value was apparent
between patients undergoing CUF and MUF (P = .40), and
there was a trend toward a higher hematocrit value after dis-
continuation of ultrafiltration in the MUF group (P = .08;
Figure 2). In patients undergoing MUF, the hematocrit value
immediately before ultrafiltration (after CPB) was signifi-
cantly lower than at baseline (34.4% ± 6.7% vs 28.1% ±
6.4%; P < .001), and there was a significant increase in
hematocrit from the initiation to the completion of MUF
(28.1% ± 6.4% vs 38.7% ± 7.5%; P < .001). The hematocrit
value after MUF was significantly higher than at baseline
(Figure 2). In patients undergoing CUF, the hematocrit
value after discontinuation of CPB did not differ signifi-
cantly from baseline (Figure 2). By repeated-measures
ANOVA, however, there was no difference between CUF
and MUF groups in the change in hematocrit value from
baseline to post-ultrafiltration measurements (P = .87).
No difference existed between CUF and MUF groups in
the indexed volume of packed red blood cells and whole
blood in the CPB prime or in the total blood received in the
operating room (including that in the prime and that admin-
TABLE 1. Demographic variables in patients undergoing
CUF and MUF
Variable CUF (n = 67) MUF (n = 43) P value
Age (mo) 9.0 ± 11.3 12.6 ± 14.1 .15
Weight (kg) 6.5 ± 3.2 7.7 ± 3.2 .07
Height (cm) 66 ± 12 66 ± 22 .97
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istered during CPB) (Figure 3). During the first 48 hours
after surgery, there was no difference between groups in the
indexed volume of blood transfused (Figure 3). 
No differences were found between groups in the pro-
portion of patients who received platelet transfusions (CUF
28% vs MUF 32%; OR = 0.84; 95% CI = 0.37-1.9; P = .68)
or fresh frozen plasma (CUF 82% vs MUF 70%; OR = 1.9;
95% CI = 0.79-4.8; P = .14) postoperatively, and no differ-
ences were observed in the volume of these products trans-
fused in those who did receive them (platelets: 12.8 ± 4.9 vs
12.0 ± 3.8 mL/kg; P = .62; plasma: 20.4 ± 9.1 vs 18.4 ± 6.6
mL/kg; P = .28). Chest tube drainage during the first 48
hours after surgery was greater in patients randomized to
MUF than those who received CUF (Table 2).
The durations of postoperative mechanical ventilatory sup-
port, stay in the intensive care unit, and hospitalization did not
differ between patients undergoing CUF and MUF (Table 3).
Discussion
CPB is a double-edged sword. Without it, corrective car-
diac surgery would not be possible in the majority of chil-
dren with congenital heart disease. However, much of the
perioperative morbidity that occurs after cardiac surgery
can be attributed in large part to pathophysiologic
processes engendered by extracorporeal circulation.12
One of the challenges that has confronted practitioners of
pediatric cardiac surgery has been to minimize the conse-
quences of CPB. Ultrafiltration is a strategy that has been
used for many years in an effort to attenuate the effects of
hemodilution that occur when small children undergo
surgery with CPB. Over the past several years, a modified
technique of ultrafiltration, commonly known as MUF,
has been used with increasing enthusiasm. When Naik,
Knight, and Elliott2 first applied this strategy of ultrafil-
tration after discontinuation of CPB, the basis of their
Figure 1. Hemodynamics and ventricular function in patients undergoing hemoconcentration with CUF (white
bars) and MUF (hatched bars). A, Heart rate before CPB (baseline), 10 minutes after the discontinuation of CPB
(CUF group) or ultrafiltration (MUF group), and 1 hour after CPB/ultrafiltration. B, Mean arterial blood pressure at
the same time points. C, Left ventricular shortening fraction determined by transesophageal echocardiography
before CPB, at the discontinuation of CPB/ultrafiltration, and 10 minutes after CPB/ultrafiltration. P values depict-
ed are for independent samples t test comparison of CUF and MUF at each time point. Trends over time did not dif-
fer significantly by repeated-measures ANOVA (see text).
A B
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approach was the removal of a greater volume of fluid
than they had been able to achieve with CUF.
Since this modified technique of post-CPB arteriovenous
ultrafiltration was initially reported in 1991, a number of
investigations have been performed on the effects of MUF in
human children undergoing cardiac surgery with CPB.2-11 The
purported benefits of MUF shown in these studies, usually in
comparison with patients not receiving any ultrafiltration,
include the following: decreased total body water,2 higher sys-
temic arterial blood pressure,2,3 decreased duration of postop-
erative inotropic support,6 improved preload recruitable stroke
work,6 improved oxygenation,5 better pulmonary compli-
ance,9 decreased duration of ventilatory support,5 higher post-
operative hematocrit value,3,7,8 lower postoperative blood
loss2,3 and requirement for blood transfusion,2,4,5,7,10 higher
concentrations of plasma proteins and fibrinogen,8 less pro-
duction of thromboxane B211 and activation of complement,4
decreased pleural effusions,5,10 and shorter duration of hospi-
talization.10 Other studies have documented removal of
vasoactive substances and inflammatory cytokines in the efflu-
Figure 2. Packed red blood cells and whole blood received in patients undergoing CUF (white bars) and MUF
(hatched bars) in the CPB priming solution, in the operating room (OR) (in the prime and during CPB), and over the
first 48 hours postoperatively. P values depicted are for independent samples t test comparison of CUF and MUF
at each time point.
TABLE 2. Fluid and ultrafiltration data in patients undergoing CUF and MUF
Variable CUF (n = 67) MUF (n = 43) P value
Total fluid received in prime and during CPB (mL/kg) 205 ± 123 162 ± 74 .05
Priming volume (mL/kg) 106 ± 51 87 ± 36 .04
Fluid added during CPB (mL/kg) 102 ± 86 80 ± 48 .55
Urine output on CPB (mL/kg) 11 ± 17 12 ± 20 .87
Effective fluid balance (mL/kg) 189 ± 112 154 ± 70 .09
Ultrafiltrate volume (mL/kg) 96 ± 63 69 ± 28 .01
Percent effective fluid balance filtered 50 ± 13 47 ± 11 .23
Percent of patients within 10% of goal ultrafiltrate volume* 82 78 .45
Chest tube drainage during the first 48 hours after surgery (mL/kg) 17.8 ± 7.0 26.6 ± 11.0 <.001
*As defined in the methods section.
TABLE 3. Postoperative resource use in patients undergoing CUF and MUF
Variable CUF (n = 67) MUF (n = 43) P value
Duration of mechanical ventilation (d) 2.6 ± 1.4 2.5 ± 0.9 .82
Duration of intensive care unit stay (d) 4.6 ± 1.8 5.0 ± 1.5 .21
Duration of postoperative hospitalization (d) 6.5 ± 1.4 7.0 ± 1.6 .09
Thompson et al Surgery for Congenital Heart Disease
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ent from ultrafiltration,13 and animal studies have demonstrat-
ed other potential benefits of MUF.14,15 Despite this mounting
evidence in support of a strategy of aggressive fluid removal,
these reports supply little information about MUF as a tech-
nique, relative to the technique of CUF, and the only clear ben-
efit of MUF over CUF remains the ability to remove a greater
volume of fluid without giving additional crystalloid solution
or blood.
In the present study, we tested the hypothesis that CUF
and MUF will not differ in their clinical effects when a stan-
dardized volume of fluid is removed on the basis of patient
weight and the volume added in the prime and during CPB.
Our findings support this hypothesis. Patients randomized to
volume-standardized CUF did not differ from those ran-
domized to volume-standardized MUF with respect to effi-
cacy of hemoconcentration (ie, pre-CPB vs post-CPB
hematocrit), requirement for postoperative blood products,
hemodynamics, ventricular function, duration of mechani-
cal ventilation, or duration of the stay in the intensive care
unit and hospital. Patients undergoing CUF did have a
greater indexed volume of fluid removed during ultrafiltra-
tion, but there was no difference in the percentage of effec-
tive fluid balance that was removed. Rather, the difference
in ultrafiltrate volume was a function of a greater indexed
prime volume in patients undergoing CUF.
Inherent in any study of ultrafiltration is the problem of
standardization and comparability. Namely, CUF and MUF
are both nonuniform practices, which typically differ from
center to center. With respect to this issue, it is important to
acknowledge that CUF and MUF should be considered both
techniques and strategies. As a technique, MUF involves
ultrafiltration after discontinuation of CPB, using either
arteriovenous or venovenous filtration, whereas CUF is per-
formed during the rewarming phase of CPB. An important
technical difference between CUF and MUF is that, where-
as CUF is performed during CPB and is therefore integrat-
ed into the perfusion routine with no additional time or risk,
MUF necessitates an additional period of extracorporeal cir-
culation at an important juncture in the operation. As strate-
gies, MUF and CUF are represented by a wide spectrum of
practices. The most significant variable is the aggressive-
ness with which hemoconcentration is pursued or, in other
words, with which fluid is removed. A greater volume of
fluid can often be removed with aggressive MUF than with
CUF, assuming that no additional fluid is added to the CPB
circuit during CUF, and this may have a significant effect on
the clinical impact of ultrafiltration. 
In the present study, we standardized the strategies of
CUF and MUF by regulating the volume of fluid removed
on the basis of patient weight and the total volume of fluid
added during CPB (including priming and cardioplegic
solutions). The purpose of this design was to compare CUF
and MUF as techniques, without the confounding effect of
differences in strategy. It might be argued that the volume-
standardized MUF performed in our study was not truly
MUF, inasmuch as the volume of fluid removed was limit-
ed. This is a troublesome objection, because it begs the
question, “What is MUF?” Clearly, our technique was that
of arteriovenous MUF, and even though the volume-
standardized method that we used may have been less
aggressive than the approach to MUF at many centers, the
mean increase in hematocrit value after MUF in our patients
was 10 points (ie, from 28% to 38%), indicating substantial
hemoconcentration. However, this is an issue of strategy
rather than technique, and there are numerous strategies of
MUF, not to mention ultrafiltration altogether. Ultimately,
we do not think that the volume-standardized design
detracts from our study, for, to reiterate, strategies of ultra-
filtration are incredibly variable and our objective was to
compare techniques rather than strategies.
The optimal approach to ultrafiltration in infants and young
children undergoing cardiac surgery with CPB remains uncer-
tain. The deleterious effects of CPB likely begin in the very
early stages of extracorporeal circulation. Thus, although
ultrafiltration during rewarming and after CPB may attenuate
the pathophysiologic processes engendered by CPB, it will not
prevent them altogether. Although ultrafiltration can remove
cytokines involved in the pathophysiologic cascades resulting
from CPB, it is not clear that this mechanism, as opposed to
the simple removal of extra fluid, translates into improved
clinical outcome, as discussed in a recent article by
Ramamoorthy and Lynn.16 The kinetics of CPB-related
cytokine elaboration and complement activation have not been
well characterized, nor has the issue of when in the course of
this process removal of such substances by ultrafiltration can
be expected to result in a meaningful reduction in the systemic
Figure 3. Hematocrit value before CPB (white bars) and after dis-
continuation of CPB/ultrafiltration (hatched bars) in patients
undergoing hemoconcentration with CUF and MUF. P values
depicted are for independent samples t test comparison of pre-
CPB and post-CPB hematocrit for CUF and MUF groups, respec-
tively. Trends over time did not differ significantly by repeated-
measures ANOVA (see text).
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inflammatory response to CPB. Regardless, it is likely that the
earlier ultrafiltration—or removal of vasoactive substances
and cytokines by other means—is initiated, the more effective
such measures will be. CUF during rewarming or earlier initi-
ation of ultrafiltration with zero-balance ultrafiltration (not
investigated in the present report) at the initiation of CPB are
likely beneficial even if aggressive MUF is used after CPB. 
Strategies of ultrafiltration need not be either/or, as the
various techniques may be used separately or in combina-
tion. Different centers use MUF and CUF differently, with
varying strategies and goals. If the goal is simply to achieve
effective hemoconcentration, aggressive MUF alone may be
adequate, as may aggressive CUF. However, if the objective
is to reap the maximum benefit of ultrafiltration, including
both hemoconcentration and removal of vasoactive and
chemoactive substances elaborated in response to CPB, it is
likely that earlier initiation of ultrafiltration is advisable. In
one of the few studies to compare combined ultrafiltration
during CPB (zero-balance ultrafiltration in this case) and
MUF with MUF alone, Journois and associates17 observed
superior hemostasis and ventilatory function in patients
undergoing both. Such data, and the general lack of clarity
regarding the optimal strategy of ultrafiltration after cardiac
surgery in children, highlight the need for further studies
into the optimal approach to hemoconcentration in the pedi-
atric population. The present study demonstrates that CUF
and MUF are not substantially different from a technical
point of view. The question of optimal ultrafiltration strate-
gy remains open.
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Discussion
Dr William Gaynor (Philadelphia, Pa). In this study, the
authors assessed the effects of ultrafiltration during or after CPB in
children. In both groups ultrafiltration was terminated after a pre-
determined volume of fluid was removed. Because of this study
design, it is not surprising that the authors found no significant dif-
ferences between the groups in hematocrit values, hemodynamic
parameters, or postoperative course. 
The use of ultrafiltration after CPB, or MUF, was introduced by
Martin Elliott and his associates in London to ameliorate some of
the adverse effects of CPB and because of the limited ability of
ultrafiltration during bypass to remove fluid and prevent the
increase in total body water. 
The use of ultrafiltration (or MUF) after CPB has been shown
to be significantly more effective than ultrafiltration during bypass
(or CUF) in reducing the increase in total body water after bypass.
This is not due to any special effect of MUF but rather to the abil-
ity, as the authors note, to remove a greater volume of filtrate in the
post-CPB period. Use of MUF results in significant improvements
in cardiac index and systolic blood pressure with a decrease in pul-
monary vascular resistance, and these have been shown to correlate
in a linear fashion with the fluid removal and the degree of hemo-
concentration. In an animal study, the use of CUF was shown to
prevent neither weight gain during CPB nor myocardial edema and
did not improve hemodynamic parameters, whereas the use of
MUF significantly reduced both weight gain and myocardial
edema. 
In addition, when the concentrations of inflammatory media-
tors in the ultrafiltrate are examined, there is no difference in the
ultrafiltrate between CUF and MUF; however, because the volume
Thompson et al Surgery for Congenital Heart Disease
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Dr Roger B. B. Mee (Cleveland, Ohio). Could I clarify one
thing? At the point of termination of CPB for the 2 groups, what
was the comparison of hematocrit values?
Dr Thompson. Hematocrit value was lower in the patients that
had MUF before removal of the fluid, but immediately after MUF
it was no different from CUF patients. 
Dr Constantine Mavroudis (Chicago, Ill). Like many of us
who do use MUF, I think you are wrong. I feel like I’m that old,
gray-haired senator sitting in the back being explained why the
Vietnam War was good. And he said, “I just can’t believe it, but I
see all these statistics.”
I do not have any data to refute what you have to say, but I think
it is wrong, and I will tell you why. Your data are not nearly as good
as Martin Elliott’s data. Don’t you agree? He used unprecedented
ventricular function studies by inflow inclusion and so on, and that
was a study for the ages. You say that you have hemodynamic evi-
dence that there is no difference between CUF and MUF, but you
really do not have hemodynamic evidence. You have a few
echocardiograms, but you do not have hemodynamic evidence to
the extent that Martin Elliott’s study has. 
Furthermore, there are a couple of things that not even Martin
studied. For instance, when you do ultrafiltration and you hemo-
concentrate the patient, what are you doing to that dopamine and
dobutamine that you have running? You did not account for that in
your analysis. Will all the patients have 5 and 5 of dopamine and
dobutamine or 5 of dobutamine? Did they have 3? And so forth. 
You may say that it does not matter because you are prospec-
tively randomizing these patients: One of them is CUF and anoth-
er is MUF. However, if your groups were different in the amount
of pressure agents they were getting at the start of the MUF, that
would definitely affect your results. 
Your study was well conceived. I guess I would have added a
third arm—both MUF and CUF. I think one of the reasons your
paper was included in this program is that it is controversial, and it
provoked a good discussion.
Dr Thompson. What I was trying to do is look at a clinical out-
come in a study that was conservatively done, without bias if pos-
sible. 
There was no increase in inotropic agents, and the requirement
for inotropic agents for both groups was about the same when we
looked at it, so I cannot say that your statement is wrong. What I
am trying to do is show you the data that I have. 
Dr Marshall Jacobs (Philadelphia, Pa). Had you not present-
ed both strategies as having as their primary purpose hemoconcen-
tration, I would not ask this question, because if you were going to
talk about removal of cytokines and myocardial depressant factors,
I think that the issues are very different. However, if the primary
motivation for a strategy of ultrafiltration is hemoconcentration, I
would simply suggest planning the bypass prime such that the
hematocrit value is between 26% and 30%. There is some experi-
mental evidence, at least in part from Dr Jonas’ laboratory, that
may enhance cerebral protection. It does not alter blood use a great
deal. In the vast majority of cases, we manage these patients with-
out the use of ultrafiltration. We use it in perhaps in no more than
10% of cases with comparable clinical outcome. 
Although I have no objections to ultrafiltration, I think if you
select a predetermined hematocrit value of 18%, then you make
of ultrafiltrate removed is significantly greater with MUF, removal
of mediators is significantly greater. 
A variety of criteria have been suggested for termination of
MUF, including a target hematocrit value, complete salvage of cir-
cuit contents, and a time end point with an MUF duration of 15 to
20 minutes. A survey of perfusion practices at 22 centers using
MUF revealed that 45% performed MUF until the circuit contents
were completely salvaged, 23% used a time criterion, 18% used a
combination of parameters, and only 1 based termination of MUF
on removal of a predetermined volume of filtrate. 
Considerable controversy remains over the optimal method for
use of ultrafiltration during and after CPB in infants. At Children’s
Hospital of Philadelphia, we aggressively use both CUF and MUF
in all neonates and infants, including those undergoing staged
reconstruction for hypoplastic left heart syndrome. In an 18-month
period, MUF was performed in 467 patients weighing less than 15
kg, at a median age of 4 months and a median weight of 5 kg. CUF
was used in 87% of these patients. MUF is continued until the cir-
cuit contents have been completely salvaged. The mean volume of
filtrate removed was 130 mL/kg and was greater than 100 mL/kg
in 65% of the patients and greater than 150 mL/kg in 30%. The
hematocrit value at the termination of bypass was 25% and
increased to 40%. The mean duration of MUF was 12 minutes, and
there were no MUF-related complications. 
I have several questions for the authors. 
As this was a prospective randomized study, why was the CUF
group so much larger than the MUF group? Also, were the diag-
noses and procedures performed distributed equally between the
groups? 
How was the volume of filtrate to be removed determined? Was
this based on a preliminary study of efficacy or simply an arbitrary
value that was chosen? 
What was the hematocrit value at the time of separation from
CPB in the patients undergoing MUF? Did MUF result in an
increase in hematocrit? If no increase in hematocrit is seen, it is
unlikely to see a positive benefit. 
Since the authors now agree that MUF is more effective than
CUF at removal of fluid after CPB, have they altered their tech-
nique and use of ultrafiltration during and after CPB? 
Dr Thompson. Regarding the distribution of patients between
the MUF and CUF groups, this was a prospective randomized
study and that is just the way our numbers turned out. Perhaps if
we had done 200 cases the distribution would have evened out, but
we are reporting the figures that we obtained. 
We did preliminarily look at the volume and determine how
much fluid we could remove from these patients rather than trying
to remove as much as we possibly could. If you are going to stan-
dardize the volume, you have to determine a percentage and not
just remove fluid arbitrarily. 
Have we changed our approach to ultrafiltration? We individu-
alize these patients according to what type of disease process they
have, how long it is going to take to repair the defects, and whether
we need to have some supplemental ultrafiltration in the patients. 
We are not trying to convince anyone that MUF is bad.
However, there is nothing magical about MUF. We are just saying
that it is no different from CUF as a technique. Strategy is a dif-
ferent issue. 
228 The Journal of Thoracic and Cardiovascular Surgery • August 2001
ED
ITO
RIA
L
CH
D
CH
D
A
CD
ET
CSP
TX
your choice between the two forms of ultrafiltration. If you select
a hematocrit value on bypass that is considerably higher, you may
not have to use either tool. 
Dr Thompson. MUF is actually labor intensive. We must pay
close attention while the patient is being subjected to MUF. After
we do these complex cases, we think that the surgeon’s attention to
the postoperative hemodynamics and to bleeding or other technical
aspects of the operation is very important. For that reason, MUF
sometimes can be very cumbersome to use. 
However, I do not think MUF is overly cumbersome in com-
plex cases in which the patient is going to be difficult to wean
from CPB because of fluid overload. Then MUF might be help-
ful in removing the excess water from those patients. Ultimately,
the decision is one that requires a risk-benefit assessment.
Our study was not meant to measure myocardial edema and
swelling. It was meant to determine whether clinical outcome
differed between patients receiving CUF and those receiving
MUF.
Surgery for Congenital Heart Disease Thompson et al
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